Microbot Medical (MBOT) Non-Current Deffered Revenue (2010 - 2016)

Microbot Medical (MBOT) has 7 years of Non-Current Deffered Revenue data on file, last reported at $16639.0 in Q3 2016.

• Quarterly Non-Current Deffered Revenue fell 99.0% year-over-year to $16639.0 in Q3 2016, while the trailing twelve-month figure through Sep 2016 was $16639.0 (down 99.0% YoY) and the FY2015 annual result came in at $1.6 million, changed N/A from the prior year.
• Non-Current Deffered Revenue slipped to $16639.0 in Q3 2016, from $20845.0 in the prior quarter.
• In the past five years, Non-Current Deffered Revenue ranged from a high of $1.8 million in Q3 2013 to a low of $16639.0 in Q3 2016.
• A 5-year average of $1.0 million and a median of $1.4 million in 2012 frame the typical range for Non-Current Deffered Revenue.
• Annual changes were most pronounced in 2015 — Non-Current Deffered Revenue jumped 3193.49% — and 2016, when it slumped 99.0%.
• Tracing MBOT's Non-Current Deffered Revenue over 5 years: stood at $1.4 million in 2012, then sank by 95.47% to $62910.0 in 2013, then jumped by 2656.66% to $1.7 million in 2014, then slipped by 6.51% to $1.6 million in 2015, then slumped by 98.97% to $16639.0 in 2016.
• The last three Non-Current Deffered Revenue figures came in at $16639.0 (Q3 2016), $20845.0 (Q2 2016), and $25052.0 (Q1 2016), per Business Quant data.